Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques.

Real-Fernández F, Pregnolato F, Cimaz R, Papini AM, Borghi MO, Meroni PL, Rovero P.

Anal Biochem. 2018 Nov 22;566:133-138. doi: 10.1016/j.ab.2018.11.018. [Epub ahead of print]

PMID:
30471243
2.

Risks associated with use of TNF inhibitors in children with rheumatic diseases.

Marino A, Giani T, Cimaz R.

Expert Rev Clin Immunol. 2018 Nov 19:1-10. doi: 10.1080/1744666X.2019.1550359. [Epub ahead of print]

PMID:
30451548
3.

Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.

Marino A, Stagi S, Simonini G, Carli N, Caparello MC, Giani T, Pagnini I, De Masi S, Cimaz R.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):929-933. Epub 2018 Jul 19.

PMID:
30148444
4.

A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.

Maccora I, Frongia I, Azzari C, Ricci S, Cimaz R, Simonini G.

Clin Exp Rheumatol. 2018 Jul 19. [Epub ahead of print] No abstract available.

PMID:
30148442
5.

Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation.

Mazzoni A, Maggi L, Siracusa F, Ramazzotti M, Rossi MC, Santarlasci V, Montaini G, Capone M, Rossettini B, De Palma R, Kruglov A, Chang HD, Cimaz R, Maggi E, Romagnani S, Liotta F, Cosmi L, Annunziato F.

Eur J Immunol. 2018 Aug 24. doi: 10.1002/eji.201847677. [Epub ahead of print]

PMID:
30144030
6.

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.

Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G, Ravelli A, Taddio A, Zulian F, Cimaz R; Rheumatology Italian Study Group.

Pediatr Rheumatol Online J. 2018 Jul 11;16(1):46. doi: 10.1186/s12969-018-0255-8. Review.

7.

Common symptoms for a rare disease in a girl with sarcoidosis: a case report.

Giovannini M, Luzzati M, Ferrara G, Buccoliero AM, Simonini G, de Martino M, Cimaz R, Giani T.

Ital J Pediatr. 2018 Jun 28;44(1):74. doi: 10.1186/s13052-018-0517-6.

8.

The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.

Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M.

Autoimmun Rev. 2018 Aug;17(8):768-774. doi: 10.1016/j.autrev.2018.01.024. Epub 2018 Jun 6.

PMID:
29885546
9.

Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Consolaro A, Bovis F, Pistorio A, Cimaz R, De Benedetti F, Miniaci A, Corona F, Gerloni V, Martino S, Pastore S, Barone P, Pieropan S, Cortis E, Podda RA, Gallizzi R, Civino A, La Torre F, Rigante D, Consolini R, Maggio MC, Magni-Manzoni S, Perfetti F, Filocamo G, Toppino C, Licciardi F, Garrone M, Scala S, Patrone E, Tonelli M, Tani D, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Jul;38(7):1311-1313. doi: 10.1007/s00296-018-4042-0.

PMID:
29786780
10.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 May 17. doi: 10.1007/s10067-018-4119-x. [Epub ahead of print]

PMID:
29770930
11.

How advances in personalized medicine will change rheumatology.

Selmi C, Kon E, De Santis M, Favalli EG, Cimaz R, Generali E, Sinigaglia L.

Per Med. 2018 Mar;15(2):75-78. doi: 10.2217/pme-2017-0079. Epub 2018 Feb 2. No abstract available.

PMID:
29714121
12.

Correction to: A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R; for EUROFEVER and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29. doi: 10.1186/s12969-018-0241-1.

13.

Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.

Marrani E, Foeldvari I, Lopez JA, Cimaz R, Simonini G.

Semin Arthritis Rheum. 2018 Mar 14. pii: S0049-0172(17)30802-8. doi: 10.1016/j.semarthrit.2018.03.003. [Epub ahead of print] Review.

PMID:
29655520
14.

Treating juvenile idiopathic arthritis to target: recommendations of an international task force.

Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.

Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030. Epub 2018 Apr 11.

PMID:
29643108
15.

The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Consolaro A, Bovis F, Pistorio A, Cimaz R, De Benedetti F, Miniaci A, Corona F, Gerloni V, Martino S, Pastore S, Barone P, Pieropan S, Cortis E, Podda RA, Gallizzi R, Civino A, Torre F, Rigante D, Consolini R, Maggio MC, Magni-Manzoni S, Perfetti F, Filocamo G, Toppino C, Licciardi F, Garrone M, Scala S, Patrone E, Tonelli M, Tani D, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):251-258. doi: 10.1007/s00296-018-3960-1. Epub 2018 Apr 7. Erratum in: Rheumatol Int. 2018 May 21;:.

16.

S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome.

Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH.

Rheumatology (Oxford). 2018 Apr 7. doi: 10.1093/rheumatology/key090. [Epub ahead of print]

PMID:
29635517
17.

Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations.

Marino A, Real-Fernández F, Rovero P, Giani T, Pagnini I, Cimaz R, Simonini G.

Clin Rheumatol. 2018 May;37(5):1407-1411. doi: 10.1007/s10067-018-4057-7. Epub 2018 Mar 5.

PMID:
29508177
18.

Inflammatory morphea presenting as a hemifacial acquired port-wine stain.

Bassi A, Piccini P, Filippeschi C, Oranges T, Giani T, Neri I, Cimaz R, Martino M.

Arch Dis Child. 2018 Feb 15. pii: archdischild-2017-314721. doi: 10.1136/archdischild-2017-314721. [Epub ahead of print] No abstract available.

PMID:
29449213
19.

Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA).

De Lucia O, Ravagnani V, Pregnolato F, Hila A, Pontikaki I, Gattinara M, Romano M, Gerloni V, Pieropan S, Murgo A, Rossini M, Cimaz R, Meroni PL.

Ann Rheum Dis. 2018 Oct;77(10):1426-1431. doi: 10.1136/annrheumdis-2017-211696. Epub 2018 Feb 6.

PMID:
29437586
20.

A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R.

Pediatr Rheumatol Online J. 2017 Dec 21;15(1):84. doi: 10.1186/s12969-017-0213-x. Erratum in: Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29.

21.

Joint pain management in children and adolescents.

Marrani E, Maccora I, Giani T, Simonini G, Cimaz R.

Minerva Pediatr. 2018 Feb;70(1):79-97. doi: 10.23736/S0026-4946.17.05137-4. Epub 2017 Nov 21. Review.

PMID:
29160644
22.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

23.

Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.

Jamilloux Y, Lefeuvre L, Magnotti F, Martin A, Benezech S, Allatif O, Penel-Page M, Hentgen V, Sève P, Gerfaud-Valentin M, Duquesne A, Desjonquères M, Laurent A, Rémy-Piccolo V, Cimaz R, Cantarini L, Bourdonnay E, Walzer T, Py BF, Belot A, Henry T.

Rheumatology (Oxford). 2018 Jan 1;57(1):100-111. doi: 10.1093/rheumatology/kex373.

PMID:
29040788
24.

2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.

Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, Chung L, Danko K, Fiorentino D, García-De la Torre I, Reed AM, Wook Song Y, Cimaz R, Cuttica RJ, Pilkington CA, Martini A, van der Net J, Maillard S, Miller FW, Vencovsky J, Aggarwal R; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Rheumatology (Oxford). 2017 Nov 1;56(11):1884-1893. doi: 10.1093/rheumatology/kex226.

25.

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.

Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1046-1051. doi: 10.1002/acr.23435. Epub 2018 Apr 24.

PMID:
28973842
26.

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.

Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.

Am J Ophthalmol. 2018 Mar;187:158-166. doi: 10.1016/j.ajo.2017.08.017. Epub 2017 Sep 6.

PMID:
28887115
27.

Sex Differences in Pediatric Rheumatology.

Cattalini M, Soliani M, Caparello MC, Cimaz R.

Clin Rev Allergy Immunol. 2017 Aug 28. doi: 10.1007/s12016-017-8642-3. [Epub ahead of print] Review.

PMID:
28849549
28.

Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports.

Maggio MC, Mastrangelo G, Skabar A, Ventura A, Carrozzi M, Santangelo G, Vanadia F, Corsello G, Cimaz R.

J Med Case Rep. 2017 Aug 16;11(1):225. doi: 10.1186/s13256-017-1388-y.

29.

Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.

Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.

Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.

30.

How I treat juvenile idiopathic arthritis: A state of the art review.

Cimaz R, Marino A, Martini A.

Autoimmun Rev. 2017 Oct;16(10):1008-1015. doi: 10.1016/j.autrev.2017.07.014. Epub 2017 Aug 1. Review.

PMID:
28778702
31.

Physical Exercise and Physical Activity for Children and Adolescents With Juvenile Idiopathic Arthritis: A Literature Review.

Catania H, Fortini V, Cimaz R.

Pediatr Phys Ther. 2017 Jul;29(3):256-260. doi: 10.1097/PEP.0000000000000436. Review.

PMID:
28654499
32.

Musculin inhibits human T-helper 17 cell response to interleukin 2 by controlling STAT5B activity.

Santarlasci V, Mazzoni A, Capone M, Rossi MC, Maggi L, Montaini G, Rossettini B, Cimaz R, Ramazzotti M, Barra G, De Palma R, Maggi E, Liotta F, Cosmi L, Romagnani S, Annunziato F.

Eur J Immunol. 2017 Sep;47(9):1427-1442. doi: 10.1002/eji.201746996. Epub 2017 Jul 6.

33.

Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records.

Cimaz R, Fanti E, Mauro A, Voller F, Rusconi F.

Eur J Pediatr. 2017 Aug;176(8):1061-1065. doi: 10.1007/s00431-017-2947-3. Epub 2017 Jun 14.

PMID:
28612175
34.

Osteoporosis in childhood.

Vierucci F, Saggese G, Cimaz R.

Curr Opin Rheumatol. 2017 Sep;29(5):535-546. doi: 10.1097/BOR.0000000000000423. Review.

PMID:
28582319
35.

Canakinumab for the treatment of TNF-receptor associated periodic syndrome.

La Torre F, Caparello MC, Cimaz R.

Expert Rev Clin Immunol. 2017 Jun;13(6):513-523. doi: 10.1080/1744666X.2017.1324783. Review.

PMID:
28454496
36.

An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.

Taddio A, Zennaro F, Pastore S, Cimaz R.

Paediatr Drugs. 2017 Jun;19(3):165-172. doi: 10.1007/s40272-017-0226-4. Review.

PMID:
28401420
37.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, de Oliveira SK, Lindsley CB, Pilkington CA, Punaro M, Ravelli A, Reed AM, Rouster-Stevens K, van Royen-Kerkhof A, Dressler F, Saad Magalhaes C, Constantin T, Davidson JE, Magnusson B, Russo R, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J, Ruperto N; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Ann Rheum Dis. 2017 May;76(5):782-791. doi: 10.1136/annrheumdis-2017-211401. Erratum in: Ann Rheum Dis. 2018 Apr;77(4):623.

38.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, de Oliveira SK, Lindsley CB, Pilkington CA, Punaro M, Ravelli A, Reed AM, Rouster-Stevens K, van Royen-Kerkhof A, Dressler F, Magalhaes CS, Constantin T, Davidson JE, Magnusson B, Russo R, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J, Ruperto N; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Arthritis Rheumatol. 2017 May;69(5):911-923. doi: 10.1002/art.40060. Epub 2017 Apr 6. Erratum in: Arthritis Rheumatol. 2018 Mar;70(3):467.

39.

Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.

Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.

J Rheumatol. 2017 Jun;44(6):822-826. doi: 10.3899/jrheum.161336. Epub 2017 Apr 1.

PMID:
28365583
40.

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.

Maggio MC, Corsello G, Prinzi E, Cimaz R.

Am J Case Rep. 2017 Mar 29;18:317-319.

41.

Musculoskeletal pain in children, when hypermobility is the problem.

Cattalini M, Cimaz R.

Arch Pediatr. 2017 May;24(5):421-423. doi: 10.1016/j.arcped.2017.01.021. Epub 2017 Mar 23. No abstract available.

PMID:
28343881
42.

Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary.

Marino A, Chiappini E, Cimaz R, Simonini G.

Pediatr Infect Dis J. 2017 Apr;36(4):440-441. doi: 10.1097/INF.0000000000001466. No abstract available.

PMID:
28288085
43.

Investigational drugs for treatment of juvenile idiopathic arthritis.

Mauro A, Rigante D, Cimaz R.

Expert Opin Investig Drugs. 2017 Apr;26(4):381-387. doi: 10.1080/13543784.2017.1301929. Epub 2017 Mar 12. Review.

PMID:
28277884
44.

Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Marrani E, Giani T, Simonini G, Cimaz R.

Drugs. 2017 Apr;77(6):679-695. doi: 10.1007/s40265-017-0715-3. Review.

PMID:
28271302
45.

Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis.

Dewoolkar M, Cimaz R, Chickermane PR, Khubchandani RP.

Indian J Pediatr. 2017 Apr;84(4):294-298. doi: 10.1007/s12098-017-2293-5. Epub 2017 Feb 23.

PMID:
28229369
46.

Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system.

Rosati A, Cosi A, Basile M, Brambilla A, Guerrini R, Cimaz R, Simonini G.

Joint Bone Spine. 2017 May;84(3):353-356. doi: 10.1016/j.jbspin.2016.12.004. Epub 2016 Dec 26.

PMID:
28034820
47.

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.

Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group.

Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68.

48.

Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.

Bason C, Pagnini I, Brucato A, Maestroni S, Puccetti A, Lunardi C, Cimaz R.

Lupus. 2017 Jul;26(8):835-840. doi: 10.1177/0961203316682099. Epub 2016 Dec 5.

PMID:
27913750
49.

Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities.

Shimizu C, Eleftherohorinou H, Wright VJ, Kim J, Alphonse MP, Perry JC, Cimaz R, Burgner D, Dahdah N, Hoang LT, Khor CC, Salgado A, Tremoulet AH, Davila S, Kuijpers TW, Hibberd ML, Johnson TA, Takahashi A, Tsunoda T, Kubo M, Tanaka T, Onouchi Y, Yeung RS, Coin LJ, Levin M, Burns JC; International Kawasaki Disease Genetics Consortium.

Circ Cardiovasc Genet. 2016 Dec;9(6):559-568. doi: 10.1161/CIRCGENETICS.116.001533. Epub 2016 Nov 21.

50.

Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status.

Di Paola M, Cavalieri D, Albanese D, Sordo M, Pindo M, Donati C, Pagnini I, Giani T, Simonini G, Paladini A, Lionetti P, De Filippo C, Cimaz R.

Front Microbiol. 2016 Oct 26;7:1703. eCollection 2016.

Supplemental Content

Support Center